Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

NCT05341349 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Clinical Stage IV Cutaneous Melanoma AJCC v8
Melanoma of Unknown Primary
Metastatic Malignant Neoplasm in the Brain
Metastatic Melanoma
Metastatic Mucosal Melanoma
Metastatic Ocular Melanoma
Pathologic Stage IV Cutaneous Melanoma AJCC v8

Interventions

BIOLOGICAL: Ipilimumab
BIOLOGICAL: Nivolumab
BIOLOGICAL: Pembrolizumab
RADIATION: Stereotactic Radiosurgery
PROCEDURE: Tumor Treating Fields Therapy

Sponsor

Emory University

Collaborators

[object Object]
[object Object]